Virginia Department of Health
Investigation of Meningitis and Stroke after Spinal Injections
Virginia Department of Health is working with the Centers for Disease Control (CDC) and Prevention and other states on a multi-state investigation of meningitis and strokes in patients who received spinal injections. As of October 11, 2012, VDH is reporting 30 cases (27 Virginia residents and 3 West Virginia residents) with a clinical presentation consistent with fungal infection, which includes 1 fatal case. Additional suspect cases are being investigated and the number of cases in Virginia will be updated daily. For information on national cases, please visit the CDC, http://www.cdc.gov/HAI/outbreaks/meningitis.html
All infected patients received preservative-free methylprednisolone acetate among three lots which have been voluntarily recalled by the New England Compounding Center, in Framingham, Massachusetts. VDH is working closely with Insight Imaging in Roanoke and New River Valley Surgery Center in Christiansburg to assist the 693 patients who received this medication via injection between June 28, 2012 and September 26, 2012. The manufacturer has recalled the implicated lots of the medication and the product is no longer being used.
Patients who had spinal injection procedures at these two facilities are being asked if they developed any new symptoms since their spinal injection. Patients are being advised to seek immediate evaluation and let a physician know about this investigation and the concern for possible infection. Symptoms of concern are new or worsening headache, fever, localized weakness, falls, difficulty walking, slurred speech or other symptoms that may suggest a stroke.
If you have questions or concerns that you may be experiencing illness after receiving a spinal injection, please contact your health care provider.
For more information, contact your local health department or 211.
Information for Clinicians
Additional Information:
Investigation of Meningitis and Stroke after Spinal Injections
Virginia Department of Health is working with the Centers for Disease Control (CDC) and Prevention and other states on a multi-state investigation of meningitis and strokes in patients who received spinal injections. As of October 11, 2012, VDH is reporting 30 cases (27 Virginia residents and 3 West Virginia residents) with a clinical presentation consistent with fungal infection, which includes 1 fatal case. Additional suspect cases are being investigated and the number of cases in Virginia will be updated daily. For information on national cases, please visit the CDC, http://www.cdc.gov/HAI/outbreaks/meningitis.html
All infected patients received preservative-free methylprednisolone acetate among three lots which have been voluntarily recalled by the New England Compounding Center, in Framingham, Massachusetts. VDH is working closely with Insight Imaging in Roanoke and New River Valley Surgery Center in Christiansburg to assist the 693 patients who received this medication via injection between June 28, 2012 and September 26, 2012. The manufacturer has recalled the implicated lots of the medication and the product is no longer being used.
Patients who had spinal injection procedures at these two facilities are being asked if they developed any new symptoms since their spinal injection. Patients are being advised to seek immediate evaluation and let a physician know about this investigation and the concern for possible infection. Symptoms of concern are new or worsening headache, fever, localized weakness, falls, difficulty walking, slurred speech or other symptoms that may suggest a stroke.
If you have questions or concerns that you may be experiencing illness after receiving a spinal injection, please contact your health care provider.
For more information, contact your local health department or 211.
Information for Clinicians
- Clinician Guidance from the CDC
- Virginia Clinicians' Letter: Update on Fungal Meningitis Associated with Potentially Contaminated Product (Oct 7, 2012)
- Virginia Clinicians' Letter: Meningitis and Stroke Associated with Potentially Contaminated Product (Oct 5, 2012)
Additional Information:
Comment